Skip to main content

Advertisement

SpringerLink
Log in

Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Objectives

To describe the clinical manifestations, cerebrospinal fluid (CSF) characteristics, imaging studies and prognostic factors of adverse clinical outcomes (ACO) among adults with herpes simplex virus (HSV) or varicella zoster virus (VZV) CNS infections.

Methods

Retrospective review of adult patients with positive HSV or VZV polymerase chain reaction on CSF from an observational study of meningitis or encephalitis in Houston, TX (2004–2014), and New Orleans, LA (1999–2008).

Results

Ninety-eight adults patients were identified; 25 had encephalitis [20 (20.4 %) HSV, 5 (5.1 %) VZV], and 73 had meningitis [60 (61.1 %) HSV and 13 (13.3 %) VZV]. HSV and VZV had similar presentations except for nausea (P < 0.01) and rash (P < 0.001). The CSF profile did not differ between HSV and VZV infection. Abnormal neuroimaging findings were found in 11.6 % (10/86) brain CTs and 21.3 % (16/75) brain MRIs. The EEG was abnormal in 57.9 % (11/19). Sixteen patients (16.3 %) had an ACO (10 HSV encephalitis, 3 VZV encephalitis and 3 VZV meningitis). Intravenous acyclovir administered within 48 h was protective against an ACO [OR 0.19 (0.04–0.80), P = 0.02). However, on logistic regression only Charlson comorbidity score >1 and an encephalitis presentation were independently associated with an ACO. The treatment for HSV meningitis was variable, and all patients had a good clinical outcome.

Conclusion

Alpha herpes CNS infections due to HSV and VZV infections have similar clinical and laboratory manifestations. ACO was observed more frequently in those patients with comorbidities and an encephalitis presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Norberg P. Divergence and genotyping of human α-herpesviruses: an overview. Infect Genet Evol. 2010;10:14–25.

    Article  CAS  PubMed  Google Scholar 

  2. Rouse BT, Kaistha SD. A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Clin Infect Dis. 2006;42:810–7.

    Article  PubMed  Google Scholar 

  3. Shalabi M, Whitley RJ. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006;43:1194–7.

    Article  PubMed  Google Scholar 

  4. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. Plos One. 2014;9:e104169.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995;171:857–63.

    Article  CAS  PubMed  Google Scholar 

  6. Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes. 2004;11:48A–56A.

    PubMed  Google Scholar 

  7. Raschilas F, Wolff M, Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis. 2002;35:254–60.

    Article  PubMed  Google Scholar 

  8. Whitley RJ. The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012;39:69–81.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Landry ML, Greenwold J, Vikram HR. Herpes simplex type-2 meningitis: presentation and lack of standardized therapy. Am J Med. 2009;122:688–91.

    Article  PubMed  Google Scholar 

  10. Noska A, Kyrillos R, Hansen G, Hirigoyen D, Williams DN. The role of antiviral therapy in immunocompromised patients with herpes simplex virus meningitis. Clin Infect Dis. 2015;60:237–42.

    Article  PubMed  Google Scholar 

  11. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  13. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480–4.

    Article  CAS  PubMed  Google Scholar 

  14. Puchhammer-Stöckl E, Aberle SW, Heinzl H. Association of age and gender with alphaherpesvirus infections of the central nervous system in the immunocompetent host. J Clin Virol. 2012;53:356–9.

    Article  PubMed  Google Scholar 

  15. Ihekwaba UK, Kudesia G, McKendrick MW. Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. Clin Infect Dis. 2008;47:783–9.

    Article  PubMed  Google Scholar 

  16. Choi R, Kim G-M, Jo IJ, et al. Incidence and clinical features of herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult Korean population with aseptic meningitis or encephalitis. J Med Virol. 2014;86:957–62.

    Article  PubMed  Google Scholar 

  17. Pollak L, Dovrat S, Book M, Mendelson E, Weinberger M. Varicella zoster versus herpes simplex meningoencephalitis in the PCR era. A single center study. J Neurol Sci. 2012;314:29–36.

    Article  PubMed  Google Scholar 

  18. Gibbens J. Acute aseptic meningitis. Lancet. 1931;218:12–5.

    Article  Google Scholar 

  19. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958–72.

    Article  CAS  PubMed  Google Scholar 

  20. O’Sullivan CE, Aksamit AJ, Harrington JR, Harmsen WS, Mitchell PS, Patel R. Clinical spectrum and laboratory characteristics associated with detection of herpes simplex virus DNA in cerebrospinal fluid. Mayo Clin Proc. 2003;78:1347–52.

    Article  PubMed  Google Scholar 

  21. Becerra JCL, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis. 2013;17:e529–34.

    Article  PubMed  Google Scholar 

  22. Desena A, Graves D, Warnack W, Greenberg BM. Herpes simplex encephalitis as a potential cause of anti-N-methyl-d-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurol. 2014;71:344–6.

    Article  PubMed  Google Scholar 

  23. Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-d-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord. 2014;29:90–6.

    Article  CAS  PubMed  Google Scholar 

  24. Schabitz W-R, Rogalewski A, Hagemeister C, Bien CG. VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology. 2014;83:2309–11.

    Article  PubMed  Google Scholar 

  25. Prüss H, Finke C, Höltje M, et al. N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012;72:902–11.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345:1727–33.

    Article  CAS  PubMed  Google Scholar 

  27. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17:999–1000.

    Article  CAS  PubMed  Google Scholar 

  28. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2008;47:303–27.

    Article  CAS  PubMed  Google Scholar 

  29. Aurelius E, Franzen-Röhl E, Glimåker M, et al. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis. 2012;54:1304–13.

    Article  CAS  PubMed  Google Scholar 

  30. Bergström T, Alestig K. Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir. Scand J Infect Dis. 1990;22:239–40.

    Article  PubMed  Google Scholar 

  31. Aurelius E, Forsgren M, Gille E, Sköldenberg B. Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scand J Infect Dis. 2002;34:278–83.

    Article  PubMed  Google Scholar 

  32. Omland LH, Vestergaard BF, Wandall JH. Herpes simplex virus type 2 infections of the central nervous system: a retrospective study of 49 patients. Scand J Infect Dis. 2008;40:59–62.

    Article  PubMed  Google Scholar 

  33. Miller S, Mateen FJ Jr, Aksamit AJ. Herpes simplex virus 2 meningitis: a retrospective cohort study. J Neurovirol. 2013;19:166–71.

    Article  CAS  PubMed  Google Scholar 

  34. Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients. Clin Infect Dis. 2013;57:849–52.

    Article  CAS  PubMed  Google Scholar 

  35. Momméja-Marin H, Lafaurie M, Scieux C, Galicier L, Oksenhendler E, Molina J-M. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis. 2003;37:1527–33.

    Article  PubMed  Google Scholar 

  36. Pouplin T, Pouplin JN, Van Toi P, et al. Valacyclovir for herpes simplex encephalitis. Antimicrob Agents Chemother. 2011;55:3624–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Erdem H, Cag Y, Ozturk-Engin D, et al. Results of a multinational study suggests rapid diagnosis and early onset of antiviral treatment in herpetic meningoencephalitis. Antimicrob Agents Chemother. 2015;59:3084–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;63:321–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Bernstein DI, Bellamy AR, Hook EW, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56:344–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

National Center for Research Resources (NIH-1 K23 RR018929-01A2) (PI Hasbun); Grant A Starr Foundation (PI Wootton).

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Texas Health Science Center, 6431 Fannin St. 2.112 MSB, Houston, TX, 77030, USA

    Quanhathai Kaewpoowat, Lucrecia Salazar & Rodrigo Hasbun

  2. Department of Pediatrics, University of Texas Health Science Center, Houston, TX, USA

    Elizabeth Aguilera & Susan H. Wootton

Authors
  1. Quanhathai Kaewpoowat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucrecia Salazar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Aguilera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan H. Wootton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rodrigo Hasbun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Quanhathai Kaewpoowat.

Ethics declarations

Conflict of interest

All the authors declare that they have not conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaewpoowat, Q., Salazar, L., Aguilera, E. et al. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 44, 337–345 (2016). https://doi.org/10.1007/s15010-015-0867-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-015-0867-6

Keywords

Search

Navigation